Luca Durelli

T‐helper 17 cells expand in multiple sclerosis and are inhibited by interferon‐β

Laura Conti, Francesco Novelli, Marinella Clerico, 2009, Annals of neurology.

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

Marco Rovaris, Massimo Filippi, Frederik Barkhof, 2001, The Lancet.

Natalizumab in Multiple Sclerosis: Long-Term Management

Carlo Alberto Artusi, Marinella Clerico, L. Durelli, 2017, International journal of molecular sciences.

Th22 cells are expanded in multiple sclerosis and are resistant to IFN‐β

Francesco Novelli, Marinella Clerico, Pietro Quaglino, 2014, Journal of leukocyte biology.

Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-γR2

Antonio Uccelli, Laura Conti, Francesco Novelli, 2012, The Journal of Immunology.